HDAC9 and neoplasm: The combination of this molecule (NA) with 7, 12-dimethylbenz [a] anthracene, a potent carcinogen compound, exhibited further effects: targeting the HDAC pathway, providing a novel chemoprevention strategy by combining different compounds through the control of epigenetic and microRNA biogenesis modulators in tumor development, in a time-dependent manner [226].